vaccines.watch currently displays data for >100k high-quality genomes with geotemporal sampling information (post-2010), but we demonstrate that substantial biases and geographic gaps remain in the coverage of available genomes.

Pleased to share our latest preprint describing vaccines.watch (vaccines.watch), an interactive platform enabling exploration of vaccine target diversity from global genome data: www.biorxiv.org/content/10.1...

By combining survey data with additional public data, we also found substantial global spread of high-risk E. coli clones (e.g. ST167) with NDM-5 and other carbapenemases. We found many introductions of these clones into European hospitals in 2019, albeit with limited onward nosocomial transmission.

We’re pleased to share two new preprints with results from a structured survey of carbapenem- and/or colistin-resistant Enterobacterales (CCRE), conducted in 37 European countries in 2019.
E. coli: papers.ssrn.com/sol3/papers....
K. pneumoniae: papers.ssrn.com/sol3/papers....

amr.watch can be used to assess representation of geographic regions, e.g. with countries here in white currently lacking any public genomes. See more at amr.watch/all (6/6)

Always on: all QC-d genomes with geotemporal metadata are ingested from archives, analysed in pathogen.watch and results visualised in amr.watch. Data are extracted and updated every 4h, with observed trends thus only delayed by time to genome deposition. More on filtering: amr.watch/summary (4/6)

We show disparities between high- and low-income settings, indicate vast gaps in our knowledge globally and highlight the need for ongoing, structured surveillance combined with timely data deposition (including metadata) to support public health. (3/6)

Our latest preprint is out describing amr.watch - a platform for monitoring AMR trends from global genomics data: www.biorxiv.org/content/10.1... (1/6)